Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Herr

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Urology|October 26, 2018
Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic BacteriuriaHarry Herr, Machele Donat
Urology|August 7, 2016
Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?Harry Herr, Sherri Machele Donat
Journal of Surgical Oncology|September 10, 2022
Genitourinary tumorsHarry Herr, Pramod Sogani, James Eastham
Urology|June 30, 2006
Complications after radical cystectomy: analysis of population-based dataBadrinath R Konety, Veerasathpurush Allareddy, Harry Herr
The Journal of Urology|April 13, 2004
Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group reportHarry Herr, Cheryl Lee, Sam Chang, et al.
BJU International|December 17, 2009
Narrow-band imaging cystoscopy to evaluate bladder tumours--individual surgeon variabilityHarry Herr, Machele Donat, Guido Dalbagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancerGanesh V Raj, Alexia Iasonos, Harry Herr, et al.
The Journal of Urology|August 6, 2025
"Neoadjuvant Chemotherapy with Transurethral Resection for Bladder Preservation: 15-year follow-up of the retained bladder"Sherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|September 8, 2025
Reply by AuthorsSherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|September 8, 2025
Reply by AuthorsSherri M Donat, Amy L Tin, Andrew J Vickers, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Urology|October 26, 2018
Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic BacteriuriaHarry Herr, Machele Donat
Urology|August 7, 2016
Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?Harry Herr, Sherri Machele Donat
Journal of Surgical Oncology|September 10, 2022
Genitourinary tumorsHarry Herr, Pramod Sogani, James Eastham
Urology|June 30, 2006
Complications after radical cystectomy: analysis of population-based dataBadrinath R Konety, Veerasathpurush Allareddy, Harry Herr
The Journal of Urology|April 13, 2004
Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group reportHarry Herr, Cheryl Lee, Sam Chang, et al.
BJU International|December 17, 2009
Narrow-band imaging cystoscopy to evaluate bladder tumours--individual surgeon variabilityHarry Herr, Machele Donat, Guido Dalbagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancerGanesh V Raj, Alexia Iasonos, Harry Herr, et al.
The Journal of Urology|August 6, 2025
"Neoadjuvant Chemotherapy with Transurethral Resection for Bladder Preservation: 15-year follow-up of the retained bladder"Sherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|September 8, 2025
Reply by AuthorsSherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|September 8, 2025
Reply by AuthorsSherri M Donat, Amy L Tin, Andrew J Vickers, et al.
Pageof 7